Chemotherapy for Mesothelioma

Chemotherapy remains the foundation of mesothelioma treatment for most patients. Understanding how these drugs work, what to expect, and how to manage side effects can help you navigate treatment with confidence.

Patient receiving chemotherapy treatment in modern infusion center
Modern chemotherapy infusion centers provide comfortable, supportive environments for treatment

How Chemotherapy Works

Chemotherapy uses powerful drugs to kill cancer cells or stop them from dividing. For mesothelioma, chemotherapy serves multiple purposes and is often paired with other treatment modalities. Different chemotherapy drugs target cancer through various mechanisms:

  • Primary treatment: For patients who are not candidates for surgery
  • Neoadjuvant therapy: Before surgery to shrink tumors
  • Adjuvant therapy: After surgery to kill remaining cancer cells
  • Palliative care: To relieve symptoms and improve quality of life

First-Line Chemotherapy: The Gold Standard

Pemetrexed (Alimta) + Cisplatin

Since 2004, the combination of pemetrexed and cisplatin has been the standard first-line chemotherapy for mesothelioma.

The Landmark Trial

The pivotal study showing this combination's effectiveness found that patients receiving pemetrexed plus cisplatin had a median survival of 12.1 months compared to 9.3 months with cisplatin alone—a significant improvement that established this as the standard of care.

How These Drugs Work:

  • Pemetrexed (Alimta): An antifolate drug that interferes with DNA production and cell division
  • Cisplatin: A platinum-based drug that damages cancer cell DNA
  • Synergistic effect: Together, these drugs are more effective than either alone

Treatment Schedule:

  • Typically administered every 21 days (one cycle)
  • IV infusion on day 1 of each cycle
  • Usually 4-6 cycles total
  • Each infusion takes several hours

Pemetrexed + Carboplatin

For patients who cannot tolerate cisplatin, carboplatin is often substituted:

  • Easier to tolerate: Less kidney toxicity and nausea
  • Similar effectiveness: Studies show comparable outcomes
  • Better for: Older patients or those with kidney issues

Other Chemotherapy Drugs

Gemcitabine (Gemzar)

Sometimes used in combination with cisplatin, particularly for peritoneal mesothelioma:

  • Weekly administration schedule
  • Can be used as first or second-line therapy
  • Different side effect profile than pemetrexed

Vinorelbine (Navelbine)

May be used as a single agent or in combination:

  • Weekly IV infusion or oral form
  • Sometimes used in second-line treatment
  • Different mechanism of action

Other Agents

Various other chemotherapy drugs may be used in clinical trials or specific situations:

  • Raltitrexed
  • Permetrexed as single agent
  • Experimental combinations

HIPEC: Chemotherapy for Peritoneal Mesothelioma

For peritoneal mesothelioma, a specialized form of chemotherapy delivery is often used:

Heated Intraperitoneal Chemotherapy (HIPEC)

  • Delivered during surgery: After visible tumors are removed
  • Heated solution: Chemotherapy is warmed to improve effectiveness
  • Direct contact: Bathes the abdominal cavity
  • Common drugs: Cisplatin, doxorubicin, or mitomycin
  • Significantly improves survival when combined with cytoreductive surgery

Side Effects of Chemotherapy

Understanding potential side effects helps you prepare and manage them effectively.

Common Side Effects

Understanding chemotherapy side effects helps patients prepare and manage treatment more effectively.

Nausea and Vomiting

  • Prevention is key—anti-nausea medications before and after treatment
  • Multiple drug classes available (5-HT3 antagonists, NK1 antagonists, steroids)
  • Usually worst in first few days after treatment
  • Tell your team if nausea isn't controlled—adjustments can be made

Fatigue

  • One of the most common side effects
  • Can accumulate over multiple cycles
  • Rest when needed, but gentle exercise may help
  • Usually improves after treatment completion

Low Blood Counts

  • Low white blood cells (neutropenia): Increased infection risk
  • Low red blood cells (anemia): Fatigue and weakness
  • Low platelets (thrombocytopenia): Bleeding and bruising risk
  • Growth factor injections may help

Kidney Problems

  • More common with cisplatin
  • Hydration is essential before and after treatment
  • Kidney function monitored with blood tests

Pemetrexed-Specific Side Effects

Skin Rash

  • Common with pemetrexed
  • Dexamenthasone before treatment helps prevent
  • Moisturizing and avoiding sun exposure recommended

Mouth Sores (Mucositis)

  • Folic acid and vitamin B12 supplementation required
  • Good oral hygiene important
  • Soft, bland foods during flares

Low Appetite

Hair Loss (Alopecia)

  • Not all chemotherapy drugs cause hair loss
  • When it occurs, hair typically regrows after treatment completion
  • Scalp cooling caps may reduce hair loss during treatment
  • Supportive resources and wig providers available

Managing Side Effects

Proper nutrition during chemotherapy and dental care are important components of managing treatment side effects.

Tips for Managing Treatment

  • Communicate openly: Tell your team about all side effects—many can be managed
  • Take preventive medications: Don't skip anti-nausea or steroid pre-medications
  • Stay hydrated: Especially important with cisplatin
  • Rest when needed: But try gentle activity when you can
  • Eat what you can: Nutrition is important, even if appetite is poor
  • Protect yourself from infection: Hand washing, avoiding sick contacts

Preparing for Chemotherapy

Before Each Treatment

  • Blood work to check blood counts and organ function
  • Hydration (especially for cisplatin)
  • Pre-medications: Anti-nausea drugs, steroids, possibly antihistamines
  • Folic acid and B12 supplementation (for pemetrexed)

What to Bring

  • Comfortable clothing
  • Entertainment (book, tablet, music)
  • Snacks and water
  • List of current medications
  • Someone to drive you home

Monitoring Treatment Response

How Doctors Assess Response

  • Imaging studies: CT scans every 2-3 cycles
  • Tumor markers: Sometimes monitored (though not standard)
  • Symptom improvement: Reduced pain, better breathing
  • Physical examination: Changes in detectable tumors

Possible Outcomes

  • Complete response: All visible tumor disappears (rare)
  • Partial response: Tumor shrinks significantly
  • Stable disease: Tumor stays about the same
  • Progressive disease: Tumor grows despite treatment

Second-Line Chemotherapy

If first-line treatment stops working, other options may include:

  • Re-treatment with pemetrexed (if response lasted 6+ months)
  • Vinorelbine
  • Gemcitabine
  • Immunotherapy
  • Clinical trials

Chemotherapy Combinations with Other Treatments

Trimodality Therapy

For selected patients:

  1. Chemotherapy first (neoadjuvant)
  2. Surgery
  3. Radiation and/or more chemotherapy

Chemo-Immunotherapy

Emerging approach combining chemotherapy with immunotherapy drugs—currently being studied in clinical trials.

👨‍⚕️

Medically Reviewed

Dr. Emily Carter, MD

Board-Certified Medical Oncologist specializing in thoracic cancers

Last reviewed: March 2026

Sources & References

  1. Vogelzang NJ, et al. Phase III Study of Pemetrexed in Combination With Cisplatin Versus Cisplatin Alone. J Clin Oncol. 2003;21(14):2636-2644
  2. Zalcman G, et al. Bevacizumab for newly diagnosed pleural mesothelioma in the Mesothelioma Avastin Cisplatin Pemetrexed Study (MAPS). Lancet. 2016;387(10026):1405-1414
  3. NCI: Drug Therapy for Mesothelioma

How Chemotherapy Works Against Mesothelioma

Chemotherapy drugs work by interfering with the ability of cancer cells to grow and divide. In mesothelioma, the standard first-line regimen combines pemetrexed (Alimta) with cisplatin. Pemetrexed is an antifolate drug that disrupts several folate-dependent enzymatic processes essential for cell replication, including thymidylate synthase, dihydrofolate reductase, and glycinamide ribonucleotide formyltransferase. By blocking these enzymes, pemetrexed prevents cancer cells from synthesizing the nucleotides needed to replicate their DNA.

Cisplatin is a platinum-based compound that forms cross-links within and between DNA strands, preventing the DNA from being properly read and copied during cell division. The combination of pemetrexed and cisplatin attacks mesothelioma cells through complementary mechanisms, which is why this dual approach is more effective than either drug alone. In clinical trials, this combination increased median survival from approximately 9 months to 12-13 months compared to cisplatin alone.

Treatment Schedule and Administration

Chemotherapy for mesothelioma is typically administered intravenously in cycles. A standard cycle involves drug infusion on day 1 followed by a rest period of approximately 21 days, allowing the body's normal cells to recover before the next treatment. Most patients receive 4-6 cycles of first-line chemotherapy, though the exact number depends on how well the cancer responds and how the patient tolerates treatment.

Before beginning pemetrexed-based chemotherapy, patients receive folic acid supplements and vitamin B12 injections to reduce the risk of severe side effects. Folic acid is taken daily starting at least 5-7 days before the first dose and continuing throughout treatment. Vitamin B12 is administered as an intramuscular injection at least one week before treatment begins and repeated every 9 weeks. Dexamethasone, a corticosteroid, is prescribed for 3 days around each treatment cycle to prevent skin rashes.

Managing Side Effects

Common side effects of pemetrexed-cisplatin chemotherapy include fatigue, nausea, decreased appetite, and lowered blood cell counts. Fatigue is the most frequently reported side effect and can persist throughout treatment and for weeks afterward. Anti-nausea medications (antiemetics) are administered before each chemotherapy session and prescribed for home use to manage treatment-related nausea and vomiting.

Cisplatin can cause kidney damage, so patients receive intravenous fluids before and after each infusion to protect kidney function. Blood tests are performed before each cycle to monitor kidney function, liver function, and blood cell counts. If blood counts drop too low, treatment may be delayed or doses adjusted. Hearing changes (ototoxicity) and peripheral neuropathy (tingling or numbness in hands and feet) are potential long-term side effects of cisplatin that patients and their care teams should monitor.

Second-Line and Emerging Options

When mesothelioma progresses after first-line chemotherapy, options include second-line chemotherapy, immunotherapy, or enrollment in clinical trials. Nivolumab plus ipilimumab (CheckMate 743) is now approved as a first-line alternative for patients with unresectable pleural mesothelioma and can also be considered after chemotherapy failure. Single-agent chemotherapy with gemcitabine or vinorelbine may be used in second-line settings, though response rates are generally lower than with first-line treatment.